Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Acer Medical: VeriOsteo OP Obtains Medical Device Approval from Indonesia's Ministry of Health 2024-10-10 10:00
Daewoong Pharmaceutical Unveils 'Innovative Drug Delivery Technologies' in Milan--From World's First Microneedle Therapy to Once-a-Month Obesity Treatment 2024-10-10 06:16
Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine 2024-10-09 23:37
Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics 2024-10-09 23:00
Inaugural Health and Wellbeing Forum Discussed about Co-creating Healthier Hong Kong for all 2024-10-09 22:17
SERVING MORE THAN LOOKS: MAYBELLINE NEW YORK ANNOUNCES NAOMI OSAKA AS THE BRAND'S FIRST BRAVE TOGETHER AMBASSADOR 2024-10-09 21:00
Public Interest Registry Unveils Winners of 6th Annual .ORG Impact Awards at DC Ceremony Hosted by Emmy Winner Alan Cumming 2024-10-09 21:00
ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions 2024-10-09 21:00
Baird Medical Lists in the U.S. on the Nasdaq Exchange 2024-10-09 20:30
ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine 2024-10-09 20:12
International Collaboration Addresses Rising Cancer Rates in South America 2024-10-09 20:07
Nona Biosciences Enters Strategic Collaboration with OverT Bio to Advance Next-Generation Cell Therapies for Solid Tumors 2024-10-09 20:00
New INTREPID Alliance Antiviral Landscape Report Highlights Urgent Need to Bolster R&D Pipeline in Support of Global Pandemic Preparedness Efforts 2024-10-09 19:00
Spring Growth Spurt, Witsbb Vitamin D for Babies Popular at Leading Australian Pharmacy Chains 2024-10-09 16:50
Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding 2024-10-09 15:23
The CDE has Granted Breakthrough Therapy Designation to LBL-024, a Bispecific Antibody that Targets PD-L1 and 4-1BB, Developed by Leads Biolabs, for the Treatment of Extrapulmonary Neuroendocrine Carcinoma. 2024-10-09 13:38
The CDE has Granted Breakthrough Therapy Designation to LBL-024, a Bispecific Antibody that Targets PD-L1 and 4-1BB, Developed by Leads Biolabs, for the Treatment of Extrapulmonary Neuroendocrine Carcinoma. 2024-10-09 13:32
Tencent Partners with Pfizer to Launch Smart Healthcare Innovation Ecosystem - Zhang Yu Highlights "Dual-Engine" Strategy for Healthcare Digitization 2024-10-09 11:23
Joint Venture Company Established for Incubation of Early Drug Discovery Programs; Investment from Takeda, Astellas and Sumitomo Mitsui Banking 2024-10-09 10:00
AWAK Transforms into Vivance, Unveiling a New Brand Identity 2024-10-09 08:00
1 23 24 25 26 27 1596